Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

939
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
939
Vitamins01:30

Vitamins

721
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
721
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K
Erythropoiesis01:14

Erythropoiesis

4.2K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.2K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

2.0K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.0K
Structure and Function of Erythrocytes01:29

Structure and Function of Erythrocytes

1.9K
There are between 4.2 and 6 million erythrocytes, also known as red blood cells, in every microliter of blood. These cells are small, flattened biconcave discs with centers that are depressed.
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF Trial.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same author

Navigating Anemia Therapy in CKD With Hypoxia-Inducible Factor Activators: A Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Safety and Efficacy of Vadadustat Versus Darbepoetin Alfa for Chronic Kidney Disease-Related Anemia in Patients Receiving Dialysis by Baseline Erythropoiesis-Stimulating Agent Dose.

Hemodialysis international. International Symposium on Home Hemodialysis·2025
Same author

Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial.

JCO oncology practice·2025
Same author

Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney disease.

Hematology. American Society of Hematology. Education Program·2024
Same author

Sickle cell disease today: a 75-year journey from "first molecular disease" to "first gene-editing therapy".

Swiss medical weekly·2024

Related Experiment Video

Updated: Jul 4, 2025

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
11:27

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Published on: February 7, 2025

422

Macrocytic anemias.

Mark J Koury1, Daniel J Hausrath

  • 1Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA and Medical Service, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee, USA.

Current Opinion in Hematology
|February 9, 2024
PubMed
Summary

Macrocytic anemia is increasingly linked to hematological diseases like myelodysplastic syndrome. Understanding the cellular mechanisms behind this condition offers insights into red blood cell production and potential treatments.

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.6K
Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
03:19

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Published on: June 28, 2024

418

Related Experiment Videos

Last Updated: Jul 4, 2025

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
11:27

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Published on: February 7, 2025

422
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.6K
Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
03:19

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Published on: June 28, 2024

418

Area of Science:

  • Hematology
  • Cell Biology
  • Erythropoiesis

Background:

  • Macrocytic anemia is increasingly associated with hematological malignancies and myelodysplastic syndrome.
  • Understanding the intracellular mechanisms of macrocytosis is crucial for comprehending normal erythropoiesis.
  • Erythroid progenitor and precursor cell adaptations lead to the production of fewer, larger red blood cells.

Approach:

  • Review of current literature on macrocytic anemia and its underlying cellular mechanisms.
  • Analysis of inherited and acquired bone marrow diseases causing impaired erythroid cell division.
  • Investigation of cellular deficits and adaptations leading to prolonged cell division and macrocytosis.

Key Points:

  • Marrow failure diseases cause erythroid cell death due to iron and heme accumulation, resulting in macrocytic anemia.
  • Disorders limiting deoxynucleosides for DNA synthesis also induce macrocytic anemia.
  • The precise source of macrocytosis in certain diseases remains an area for further investigation.

Conclusions:

  • The cellular mechanisms driving macrocytic anemia provide a window into normal erythropoiesis.
  • Understanding these adaptations can inform the development of novel treatments for macrocytic anemia.
  • Further research is needed to elucidate the causes of macrocytosis in all disease contexts.